Characterization of Lower Urinary Tract Symptoms Before and After Midurethral Sling Revision

2016 ◽  
Vol 23 (6) ◽  
pp. 979-985 ◽  
Author(s):  
Alison M. Parden ◽  
Ying Tang ◽  
Jeff Szychowski ◽  
Holly E. Richter
2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Tomasz Rechberger ◽  
Andrzej Wrobel ◽  
Alicja Zietek ◽  
Ewa Rechberger ◽  
Beata Kulik-Rechberger ◽  
...  

Aim. Lower urinary tract symptoms (LUTS) frequently affect patients immediately after midurethral sling (MUS) placement. The objective of the study was to assess if solifenacin or mirabegron decreases incidence of LUTS in women who underwent transobturator MUS. Methods. A prospective randomized trial was conducted on patients undergoing ambulatory transobturator midurethral sling due to stress urinary incontinence (SUI). All participants were questioned before and after surgery for occurrence of bothersome LUTS. A total of 328 patients who underwent transobturator MUS were randomly assigned to one of three groups: prophylaxis with 10 mg of solifenacin, prophylaxis with 50 mg of mirabegron, or without any additional treatment. LUTS evolution and efficacy of solifenacin and mirabegron were analyzed based on results of assessments made during follow-up visits at 1 and 6 weeks after surgery. Comparison of the prevalence of LUTS was done using chi2 test. Results. Prevalence of urgency and frequency episodes increased notably 1 week after sling placement and then came down to baseline levels. Solifenacin and mirabegron significantly reduced the incidence of urgency after 1 week, but after 6 weeks the beneficial effect was observed only in case of solifenacin. Treatment with mirabegron reduced the percentage of patients suffering from frequency after 6 weeks. Although prevalence of nocturia did not raise after sling placement, both treatments significantly reduced the incidence of this complaint after 6 weeks. Pharmacological treatment did not modulate the course of hesitancy and terminal dribbling. Conclusions. Treatment with solifenacin or mirabegron may significantly reduce the incidence of undesired LUTS after MUS.


Author(s):  
Cissa Azevedo ◽  
Caroline de Castro Moura ◽  
Hérica Pinheiro Corrêa ◽  
Bianca Bacelar de Assis ◽  
Luciana Regina Ferreira da Mata ◽  
...  

ABSTRACT Objective: To analyze the evidence available in the literature on the use of auriculotherapy in adults and elderly people with lower urinary tract symptoms. Method: An integrative literature review. Primary study search was carried out in nine relevant health databases. The characterization of studies regarding the method of application of auriculotherapy was based on the Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture recommendations. Results: 296 studies were found, 17 pre-selected and eight included in the review. Favorable results from auriculotherapy were evidenced in specific populations, such as elderly men with prostatic disorders and individuals undergoing surgical procedures. The main urinary symptoms addressed were frequency, urgency, nocturia, incomplete voiding, intermittency, weak flow, effort to start urination, incontinence, and urinary retention. Conclusion: Despite the limited number of studies and weaknesses with regard to sample size and different intervention protocols, it is suggested that auriculotherapy, associated or not with other complementary therapies, may contribute to lower urinary tract symptom control in adults and elderly people.


Sign in / Sign up

Export Citation Format

Share Document